Regeneron Pharmaceuticals (REGN) Free Cash Flow Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 31.20 Bn | 31.20 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.40% |
| Dec 31, 2025 | -2.93% |
| Sep 30, 2025 | 36.95% |
| Jun 30, 2025 | 7.99% |
| Mar 31, 2025 | 9.10% |
| Dec 31, 2024 | 10.40% |
| Sep 30, 2024 | 15.27% |
| Jun 30, 2024 | 29.12% |
| Mar 31, 2024 | 10.88% |
| Dec 31, 2023 | 5.44% |
| Sep 30, 2023 | 15.82% |
| Jun 30, 2023 | 31.83% |
| Mar 31, 2023 | 17.13% |
| Dec 31, 2022 | 27.83% |
| Sep 30, 2022 | 6.49% |
| Jun 30, 2022 | 46.76% |
| Mar 31, 2022 | 45.03% |
| Dec 31, 2021 | 56.01% |
| Sep 30, 2021 | 43.86% |
| Jun 30, 2021 | 10.92% |
| Mar 31, 2021 | 64.50% |
| Dec 31, 2020 | 59.37% |
| Sep 30, 2020 | -20.55% |
| Jun 30, 2020 | 114.45% |
| Mar 31, 2020 | 34.77% |
| Dec 31, 2019 | 51.73% |
| Sep 30, 2019 | 38.80% |
| Jun 30, 2019 | -18.81% |
| Mar 31, 2019 | 137.04% |
| Dec 31, 2018 | 24.77% |
| Sep 30, 2018 | 41.66% |
| Jun 30, 2018 | 24.70% |
| Mar 31, 2018 | 52.66% |
| Dec 31, 2017 | 42.55% |
| Sep 30, 2017 | 97.60% |
| Jun 30, 2017 | 1.31% |
| Mar 31, 2017 | 38.59% |
| Dec 31, 2016 | 42.59% |
| Sep 30, 2016 | 63.18% |
| Jun 30, 2016 | 48.94% |
| Mar 31, 2016 | -12.54% |
| Dec 31, 2015 | 27.90% |
| Sep 30, 2015 | 39.89% |
| Jun 30, 2015 | 20.31% |
| Mar 31, 2015 | -46.20% |
| Dec 31, 2014 | 25.98% |
| Sep 30, 2014 | 35.87% |